Edgewise Therapeutics (EWTX) Non-cash Items (2021 - 2026)
Edgewise Therapeutics has reported Non-cash Items over the past 6 years, most recently at $1.1 million for Q1 2026.
- Quarterly results put Non-cash Items at $1.1 million for Q1 2026, down 14.84% from a year ago — trailing twelve months through Mar 2026 was $1.1 million (down 14.84% YoY), and the annual figure for FY2024 was $8.6 million, up 26.26%.
- Non-cash Items reached $1.1 million in Q1 2026 per EWTX's latest filing, down from $1.2 million in the prior quarter.
- Across five years, Non-cash Items topped out at $13.4 million in Q4 2022 and bottomed at $1.1 million in Q1 2026.
- Median Non-cash Items over the past 5 years was $1.5 million (2023), compared with a mean of $3.0 million.
- The largest annual shift saw Non-cash Items crashed 82.51% in 2022 before it changed 0.0% in 2024.
- Over 5 years, Non-cash Items stood at $13.4 million in 2022, then tumbled by 48.91% to $6.8 million in 2023, then tumbled by 32.81% to $4.6 million in 2024, then tumbled by 72.88% to $1.2 million in 2025, then dropped by 8.02% to $1.1 million in 2026.
- Business Quant data shows Non-cash Items for EWTX at $1.1 million in Q1 2026, $1.2 million in Q3 2025, and $1.3 million in Q2 2025.